文献
J-GLOBAL ID:201302268156813173
整理番号:13A0640887
タイプIIIホスファチジルイノシトール-4-キナーゼβ阻害の抗C型肝炎ウイルス活性および毒性
Anti-Hepatitis C Virus Activity and Toxicity of Type III Phosphatidylinositol-4-Kinase Beta Inhibitors
著者 (23件):
LAMARCHE M. J.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
BORAWSKI J.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
BOSE A.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
CAPACCI-DANIEL C.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
COLVIN R.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
DENNEHY M.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
DING J.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
DOBLER M.
(Novartis Pharma AG, Basel, CHE)
,
DRUMM J.
(Novartis Diagnostics and Vaccines, Inc., California, USA)
,
GAITHER L. A.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
GAO J.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
JIANG X.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
LIN K.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
MCKEEVER U.
(Novartis Pharma AG, Basel, CHE)
,
PUYANG X.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
RAMAN P.
(Astra Zeneca, Massachusetts, USA)
,
THOHAN S.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
TOMMASI R.
(Astra Zeneca, Massachusetts, USA)
,
WAGNER K.
(Novartis Pharma AG, Basel, CHE)
,
XIONG X.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
ZABAWA T.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
ZHU S.
(Novartis Inst. for Biomedical Res. Inc., Massachusetts, USA)
,
WIEDMANN B.
(Novartis Diagnostics and Vaccines, Inc., California, USA)
資料名:
Antimicrobial Agents and Chemotherapy
(Antimicrobial Agents and Chemotherapy)
巻:
56
号:
10
ページ:
5148-5156
発行年:
2012年10月
JST資料番号:
E0802A
ISSN:
0066-4804
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)